174 related articles for article (PubMed ID: 33811445)
1. CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript.
Zangrando A; Cavagnero F; Scarparo P; Varotto E; Francescato S; Tregnago C; Cuccurullo R; Fagioli F; Nigro LL; Masetti R; Putti MC; Rizzari C; Santoro N; Pession A; Pigazzi M; Locatelli F; Basso G; Buldini B
Cytometry A; 2021 Aug; 99(8):844-850. PubMed ID: 33811445
[TBL] [Abstract][Full Text] [Related]
2. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
[TBL] [Abstract][Full Text] [Related]
3. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
4. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Transcriptome Profiling of Cryptic
Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
[TBL] [Abstract][Full Text] [Related]
7. CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.
Masetti R; Pigazzi M; Togni M; Astolfi A; Indio V; Manara E; Casadio R; Pession A; Basso G; Locatelli F
Blood; 2013 Apr; 121(17):3469-72. PubMed ID: 23407549
[TBL] [Abstract][Full Text] [Related]
8. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
Masetti R; Bertuccio SN; Pession A; Locatelli F
Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
[TBL] [Abstract][Full Text] [Related]
9.
Khanlari M; Wang L; Bolen CY; Otanez FSB; Furtado LV; Key L; Irwin L; Wang W; Klco JM
EJHaem; 2023 Aug; 4(3):765-769. PubMed ID: 37601875
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
11. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
Panda D; Chatterjee G; Sardana R; Khanka T; Ghogale S; Deshpande N; Badrinath Y; Shetty D; Narula G; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 Mar; 100(2):206-217. PubMed ID: 32865882
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Pardo LM; Voigt AP; Alonzo TA; Wilson ER; Gerbing RB; Paine DJ; Dai F; Menssen AJ; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Brodersen LE; Loken MR
Cytometry B Clin Cytom; 2020 Jan; 98(1):52-56. PubMed ID: 31294507
[TBL] [Abstract][Full Text] [Related]
13. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
14. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.
Gruber TA; Larson Gedman A; Zhang J; Koss CS; Marada S; Ta HQ; Chen SC; Su X; Ogden SK; Dang J; Wu G; Gupta V; Andersson AK; Pounds S; Shi L; Easton J; Barbato MI; Mulder HL; Manne J; Wang J; Rusch M; Ranade S; Ganti R; Parker M; Ma J; Radtke I; Ding L; Cazzaniga G; Biondi A; Kornblau SM; Ravandi F; Kantarjian H; Nimer SD; Döhner K; Döhner H; Ley TJ; Ballerini P; Shurtleff S; Tomizawa D; Adachi S; Hayashi Y; Tawa A; Shih LY; Liang DC; Rubnitz JE; Pui CH; Mardis ER; Wilson RK; Downing JR
Cancer Cell; 2012 Nov; 22(5):683-97. PubMed ID: 23153540
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
17. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
[TBL] [Abstract][Full Text] [Related]
18. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
[TBL] [Abstract][Full Text] [Related]
19. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
[TBL] [Abstract][Full Text] [Related]
20. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]